scholarly article | Q13442814 |
P2093 | author name string | Chen Li | |
Avrum I Gotlieb | |||
P2860 | cites work | SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7 | Q24299813 |
Analysis of promoter binding by the E2F and pRB families in vivo: distinct E2F proteins mediate activation and repression | Q24607675 | ||
Transforming growth factor beta stabilizes p15INK4B protein, increases p15INK4B-cdk4 complexes, and inhibits cyclin D1-cdk4 association in human mammary epithelial cells | Q24646540 | ||
Mechanisms of TGF-beta signaling from cell membrane to the nucleus | Q27860785 | ||
p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest | Q28258615 | ||
The regulation of E2F by pRB-family proteins | Q28278789 | ||
TGFbeta in Cancer | Q28288866 | ||
Regulation of wound healing by growth factors and cytokines | Q29615242 | ||
Non-Smad pathways in TGF-beta signaling | Q29620040 | ||
Inhibition of autoregulated TGFbeta signaling simultaneously enhances proliferation and differentiation of kidney epithelium and promotes repair following renal ischemia | Q30487144 | ||
Cardiac valve interstitial cells secrete fibronectin and form fibrillar adhesions in response to injury | Q33291099 | ||
Mechanism of TGF-beta signaling to growth arrest, apoptosis, and epithelial-mesenchymal transition | Q33411645 | ||
Transforming growth factor beta 1 suppression of c-myc gene transcription: role in inhibition of keratinocyte proliferation | Q33583459 | ||
The Rb/E2F pathway and cancer | Q34189004 | ||
TGF-beta induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop | Q68482825 | ||
Porcine mitral valve interstitial cells in culture | Q70222637 | ||
Differential phosphorylation of the retinoblastoma protein by G1/S cyclin-dependent kinases | Q73316457 | ||
Activated interstitial myofibroblasts express catabolic enzymes and mediate matrix remodeling in myxomatous heart valves | Q77198147 | ||
Characterization of cell motility in single heart valve interstitial cells in vitro | Q80338033 | ||
Transforming growth factor-beta activation of phosphatidylinositol 3-kinase is independent of Smad2 and Smad3 and regulates fibroblast responses via p21-activated kinase-2 | Q81480914 | ||
Targeted disruption of TGF-beta-Smad3 signaling leads to enhanced neointimal hyperplasia with diminished matrix deposition in response to vascular injury | Q81575610 | ||
Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism | Q34235866 | ||
Dual regulation of proliferation and growth arrest in prostatic stromal cells by transforming growth factor-beta1. | Q34345039 | ||
Advances towards understanding heart valve response to injury. | Q34588824 | ||
Mechanisms of TGF-beta signaling in regulation of cell growth and differentiation | Q34635877 | ||
A specific inhibitor of TGF-beta receptor kinase, SB-431542, as a potent antitumor agent for human cancers. | Q34768457 | ||
Circulating transforming growth factor-beta in Marfan syndrome | Q34994399 | ||
The cardiac valve interstitial cell | Q35024662 | ||
The myofibroblast in wound healing and fibrocontractive diseases | Q35170446 | ||
Transforming growth factor-beta in disease: the dark side of tissue repair | Q35603155 | ||
Mechanotransduction at cell-matrix and cell-cell contacts | Q35837614 | ||
The role of transforming growth factor beta1 in the vascular system | Q36041400 | ||
TGF-beta-dependent cell growth arrest and apoptosis | Q36296913 | ||
Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer | Q36516410 | ||
A delicate balance: TGF-beta and the tumor microenvironment | Q36814529 | ||
The emerging role of valve interstitial cell phenotypes in regulating heart valve pathobiology | Q36933045 | ||
Distinct roles for mammalian target of rapamycin complexes in the fibroblast response to transforming growth factor-beta | Q37129967 | ||
Cytoskeletal control of growth and cell fate switching | Q37594290 | ||
TGF-beta-dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome | Q37628211 | ||
Type beta transforming growth factor: a bifunctional regulator of cellular growth | Q37672515 | ||
The response to valve injury. A paradigm to understand the pathogenesis of heart valve disease | Q37809386 | ||
SB-431542, a small molecule transforming growth factor-beta-receptor antagonist, inhibits human glioma cell line proliferation and motility. | Q38339796 | ||
Id2 suppression of p15 counters TGF-beta-mediated growth inhibition of melanoma cells | Q39860820 | ||
TGFbeta prevents proteasomal degradation of the cyclin-dependent kinase inhibitor p27kip1 for cell cycle arrest | Q39883204 | ||
TGF-beta induces growth arrest in Burkitt lymphoma cells via transcriptional repression of E2F-1. | Q39913896 | ||
TGF beta-induced growth inhibition in primary fibroblasts requires the retinoblastoma protein | Q40242882 | ||
Phenotypic characterization of isolated valvular interstitial cell subpopulations. | Q40262647 | ||
TGF-beta1-mediated activations of c-Src and Rac1 modulate levels of cyclins and p27(Kip1) CDK inhibitor in hepatoma cells replated on fibronectin | Q40445197 | ||
SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo | Q40497236 | ||
Cell biology of valvular interstitial cells. | Q40949175 | ||
The effect of TGF-beta 1 on cell proliferation and proteoglycan production in human melanoma cells depends on the degree of cell differentiation | Q41145976 | ||
Characterization of Cobblestone mitral valve interstitial cells | Q41157221 | ||
Transforming growth factor-beta inhibits phosphorylation of the retinoblastoma susceptibility gene product in human monocytic leukemia cell line JOSK-I. | Q41607585 | ||
Growth inhibition by TGF-beta linked to suppression of retinoblastoma protein phosphorylation | Q41728185 | ||
Transforming growth factor-beta regulates in vitro heart valve repair by activated valve interstitial cells | Q42160598 | ||
Interstitial cells of the heart valves possess characteristics similar to smooth muscle cells | Q42525839 | ||
TGF-beta receptor kinase inhibitor enhances growth and integrity of embryonic stem cell-derived endothelial cells | Q42917997 | ||
Transforming growth factor-beta1 modulates expression of adhesion and cytoskeletal proteins in human peritoneal fibroblasts | Q44048880 | ||
Progression of aortic valve stenosis: TGF-beta1 is present in calcified aortic valve cusps and promotes aortic valve interstitial cell calcification via apoptosis | Q44329666 | ||
Dynamic and reversible changes of interstitial cell phenotype during remodeling of cardiac valves. | Q51601913 | ||
Cyclin-dependent kinases and cell-cycle transitions: does one fit all? | Q53451934 | ||
Growth inhibition induced by transforming growth factor-beta1 in human oral squamous cell carcinoma. | Q53483198 | ||
Vascular cell apoptosis: cell type-specific modulation by transforming growth factor-beta1 in endothelial cells versus smooth muscle cells. | Q54099166 | ||
Extracellular Matrix Remodeling and Organization in Developing and Diseased Aortic Valves | Q63341951 | ||
Bovine mitral valve organ culture: role of interstitial cells in repair of valvular injury | Q68054738 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1746-1755 | |
P577 | publication date | 2011-08-16 | |
P1433 | published in | The American Journal of Pathology | Q4744259 |
P1476 | title | Transforming growth factor-β regulates the growth of valve interstitial cells in vitro | |
P478 | volume | 179 |
Q91869856 | FGF-2 inhibits contractile properties of valvular interstitial cell myofibroblasts encapsulated in 3D MMP-degradable hydrogels |
Q42501448 | Fibroblast growth factor 9 (FGF9) regulation of cyclin D1 and cyclin-dependent kinase-4 in ovarian granulosa and theca cells of cattle |
Q41022393 | Inflammation Drives Retraction, Stiffening, and Nodule Formation via Cytoskeletal Machinery in a Three-Dimensional Culture Model of Aortic Stenosis |
Q26764864 | Involvement of Immune Cell Network in Aortic Valve Stenosis: Communication between Valvular Interstitial Cells and Immune Cells |
Q26781699 | Mitral valve disease--morphology and mechanisms |
Q41651926 | Role of cell-matrix interactions on VIC phenotype and tissue deposition in 3D PEG hydrogels |
Q27336001 | Sex-related differences in gene expression by porcine aortic valvular interstitial cells |
Q36943410 | TGF-β signalling and reactive oxygen species drive fibrosis and matrix remodelling in myxomatous mitral valves |
Search more.